| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Correction to: Expression of Concern: Knockdown of eIF3d inhibits cell proliferation through G2/M phase arrest in non-small cell lung cancer
|
Lin, Zhifeng
|
|
2019
|
36 |
6 |
p. 1
|
article
|
| 2 |
Identification of candidate diagnostic and prognostic biomarkers for human prostate cancer: RPL22L1 and RPS21
|
Liang, Zumu
|
|
2019
|
36 |
6 |
p. 1-10
|
article
|
| 3 |
Influence of ABCB1 polymorphisms on the pharmacokinetics and toxicity of lenalidomide in patients with multiple myeloma
|
Kobayashi, Takahiro
|
|
2019
|
36 |
6 |
p. 1-7
|
article
|
| 4 |
Intra- and inter-observer variability in breast tumour bed contouring and the controversial role of surgical clips
|
Corrao, Giulia
|
|
2019
|
36 |
6 |
p. 1-8
|
article
|
| 5 |
Multicenter open-label randomized phase II study of second-line panitumumab and irinotecan with or without fluoropyrimidines in patients with KRAS wild-type metastatic colorectal cancer (PACIFIC study)
|
Nagata, Naoki
|
|
2019
|
36 |
6 |
p. 1-12
|
article
|
| 6 |
N-Glycosylation in progression of skin cancer
|
Tang, Ling
|
|
2019
|
36 |
6 |
p. 1-10
|
article
|
| 7 |
Performance of a new system using a one-step nucleic acid amplification assay for detecting lymph node metastases in breast cancer
|
Shimazu, Kenzo
|
|
2019
|
36 |
6 |
p. 1-8
|
article
|
| 8 |
Postmastectomy radiation therapy using VMAT technique for breast cancer patients with expander reconstruction
|
De Rose, Fiorenza
|
|
2019
|
36 |
6 |
p. 1-8
|
article
|
| 9 |
Real-world study of afatinib in first-line or re-challenge settings for patients with EGFR mutant non-small cell lung cancer
|
Tanaka, Hisashi
|
|
2019
|
36 |
6 |
p. 1-8
|
article
|
| 10 |
Subgroup analysis of efficacy and safety of orantinib in combination with TACE in Japanese HCC patients in a randomized phase III trial (ORIENTAL)
|
Hidaka, Hisashi
|
|
2019
|
36 |
6 |
p. 1-11
|
article
|
| 11 |
Timing of treatment in small-cell lung cancer
|
Bhandari, Shruti
|
|
2019
|
36 |
6 |
p. 1-5
|
article
|
| 12 |
Tumor expression and usefulness as a biomarker of programmed death ligand 1 in advanced non-small cell lung cancer patients with preexisting interstitial lung disease
|
Shibaki, Ryota
|
|
2019
|
36 |
6 |
p. 1-8
|
article
|
Journal description